购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

BX795

产品编号 T1830Cas号 702675-74-9

BX795 是一种选择性PDK1抑制剂,也是相对特异性的TBK1和IKKɛ 抑制剂。它抑制 S6K1,Akt,PKCδ 和 GSK3β 的磷酸化,可调节自噬。

BX795

BX795

纯度: 99.57%
产品编号 T1830Cas号 702675-74-9

BX795 是一种选择性PDK1抑制剂,也是相对特异性的TBK1和IKKɛ 抑制剂。它抑制 S6K1,Akt,PKCδ 和 GSK3β 的磷酸化,可调节自噬。

规格价格库存数量
1 mg¥ 218现货
5 mg¥ 488现货
10 mg¥ 913现货
25 mg¥ 1,990现货
50 mg¥ 3,230现货
100 mg¥ 4,770现货
200 mg¥ 6,780现货
500 mg¥ 9,870现货
1 mL x 10 mM (in DMSO)¥ 598现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"BX795"的相关化合物库

选择批次:
纯度:99.57%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
BX795 is an effective and selective PDK1 inhibitor (IC50: 6 nM), and its selectivity is 140- and 1600-fold for PDK1 over PKA and PKC in cell-free assays, respectively. Meanwhile, the selectivity for PDK1 is 100-fold than GSK3β.
靶点活性
PDK1:6 nM
体内活性
BX795(1 μM)对以下酪氨酸蛋白激酶无抑制作用: 肝配蛋白受体A2和B3,Bruton's酪氨酸激酶,Syk和FGFR1。但BX795对抑制血管内皮生长因子受体的抑制效果低于TBK1。BX795对IRF3 Ser396位点磷酸化(TBK1-催化)的抑制作用随着ATP浓度上升而下降,意味着BX795是ATP竞争性抑制剂。BX795也抑制NUAK1,MARK1/2/4,VEGFR和MLK1/2/3,IC50分别为5,55,53,19,157,50,46和42 nM。BX795对IRF3依赖的基因转录具有抑制作用。BX795对巨噬细胞的IFN-β分泌也有抑制作用。BX795阻断IKKε和TBK1调节的IRF3激活,并对IFN-β的产量有抑制效果。BX795对TBK1/IKKε的抑制不会引起p38α MAPK和JNK1/2的激活。BX795可抑制聚(I:C)处理后IRF3在核中的积累。BX795不影响脂多糖刺激的p70核糖体S6激酶1Thr229位点的磷酸化,该位点是PDK1的作用靶点。BX795不影响NFκB依赖的基因转录激活(由IKKα/β复合体或脂多糖、聚(I:C)、IL-1α或TNFα促进)。BX795对IL-1α或TNFα刺激的MEFs有效,并阻断p38α MAPKJ和NK1/2磷酸化。
激酶实验
Kinase assays: PDK1 is assayed in a direct kinase assay and a coupled assay format measuring PDK1- and PtdIns-3,4-P2-mediated activation of AKT2. For the coupled assay, the final assay mixture (60 μL) contained: 15 mM MOPS, pH 7.2, 1 mg/mL bovine serum albumin, 18 mM β-glycerol phosphate, 0.7 mM dithiothreitol, 3 mM EGTA, 10 mM MgOAc, 7.5 μM ATP, 0.2 μCi of [γ-33P]ATP, 7.5 μM biotinylated peptide substrate (biotin-ARRRDGGGAQPFRPRAATF), 0.5 μL of PtdIns-3,4-P2-containing phospholipid vesicles, 60 pg of purified recombinant human PDK1, and 172 ng of purified recombinant human AKT2. After incubation for 2 h at room temperature, the biotin-labeled peptide is captured from 10 μl of the assay mixture on streptavidin-coated SPA beads, and product formation is measured by scintillation proximity in a Wallac MicroBeta counter. The product formed is proportional to the time of incubation and to the amount of PDK1 and inactive AKT2 added. PDK1 is added at suboptimal levels so that the assay could sensitively detect inhibitors of AKT2 activation as well as direct inhibitors of PDK1 or AKT2. To measure PDK1 activity directly, the final assay mixture (60 μL) contained 50 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, 0.1 mM EDTA, 0.1% β-mercaptoethanol, 1 mg/mL bovine serum albumin, 10 mM MgOAc, 10 μM ATP, 0.2 μCi of [γ-33P]ATP, 7.5 μM substrate peptide (H2N-ARRRGVTTKTFCGT), and 60 ng of purified recombinant human PDK1. After 4 h at room temperature, we add 25 mM EDTA and spotted a portion of the reaction mixture on Whatman P81 phosphocellulose paper. The filter paper is washed three times with 0.75% phosphoric acid and once with acetone. After drying, the filter-bound labeled peptide is quantified using a Fuji phosphorimager.
细胞实验
Cells seeded at a low density (1,500–3,000 cells/well, 0.1 mL/well, 96-well plates) are incubated overnight. Compound treatments are made by adding 10 μL/well of the compound in 1% dimethyl sulfoxide and growth medium (final concentration of dimethyl sulfoxide, 0.1%), followed by brief shaking. Treated cells are incubated for 72 hours, and viability is measured by the addition of 10 μL of the metabolic dye WST-1. The WST-1 signal is read in a plate reader at 450 nm, and a no cell, or zero time cell, background is subtracted to calculate the net signal. Results are reported as the average ± S.E. of two or more replicates.(Only for Reference)
化学信息
分子量591.47
分子式C23H26IN7O2S
CAS No.702675-74-9
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 60 mg/mL (101.44 mM), Sonication is recommended.
Ethanol: 59.2 mg/mL (100 mM)
溶液配制表
Ethanol/DMSO
1mg5mg10mg50mg
1 mM1.6907 mL8.4535 mL16.9070 mL84.5351 mL
5 mM0.3381 mL1.6907 mL3.3814 mL16.9070 mL
10 mM0.1691 mL0.8454 mL1.6907 mL8.4535 mL
20 mM0.0845 mL0.4227 mL0.8454 mL4.2268 mL
50 mM0.0338 mL0.1691 mL0.3381 mL1.6907 mL
100 mM0.0169 mL0.0845 mL0.1691 mL0.8454 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy BX795 | purchase BX795 | BX795 cost | order BX795 | BX795 chemical structure | BX795 in vivo | BX795 formula | BX795 molecular weight